Search research articles
Contact Us
Filters
Showing results (41-50 of 80) with videos related to
Page
of 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 2017
Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer
Catherine Thompson, Nuradh Joseph, Benjamin Sanderson, et al.
Plos One
|
September 3, 2011
Evolutionary pathways of the pandemic influenza A (H1N1) 2009 in the UK
Monica Galiano, Paul-Michael Agapow, Catherine Thompson, et al.
BMC Public Health
|
August 29, 2009
Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers
Justin Mandala, Kwasi Torpey, Prisca Kasonde, et al.
European Urology
|
July 30, 2011
Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial
Francisco Cruz, Sender Herschorn, Philip Aliotta, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 7, 2022
Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment
Said Hilton, Philippe Kestemont, Gerhard Sattler, et al.
European Urology
|
April 24, 2013
OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial
Christopher Chapple, Karl-Dietrich Sievert, Scott MacDiarmid, et al.
Emerging Infectious Diseases
|
October 25, 2012
Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011
Katja Hoschler, Catherine Thompson, Nick Andrews, et al.
The Journal of Urology
|
October 19, 2010
Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial
Roger Dmochowski, Christopher Chapple, Victor W Nitti, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
August 6, 2021
Comparison of the Pharmacokinetic Profiles of Trientine Tetrahydrochloride and Trientine Dihydrochloride in Healthy Subjects
Karl Heinz Weiss, Catherine Thompson, Peter Dogterom, et al.
Clinical Infection in Practice
|
December 31, 2019
Adenovirus Type 7 causing severe lower respiratory tract infection in immunocompetent adults: a comparison of two contrasting cases from an intensive care unit in North West England
Tom Wingfield, Luke Dearden, Pete Calvert, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 80) with videos related to
Sort By:
Page
of 8
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 2017
Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer
Catherine Thompson, Nuradh Joseph, Benjamin Sanderson, et al.
Plos One
|
September 3, 2011
Evolutionary pathways of the pandemic influenza A (H1N1) 2009 in the UK
Monica Galiano, Paul-Michael Agapow, Catherine Thompson, et al.
BMC Public Health
|
August 29, 2009
Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers
Justin Mandala, Kwasi Torpey, Prisca Kasonde, et al.
European Urology
|
July 30, 2011
Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial
Francisco Cruz, Sender Herschorn, Philip Aliotta, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 7, 2022
Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment
Said Hilton, Philippe Kestemont, Gerhard Sattler, et al.
European Urology
|
April 24, 2013
OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial
Christopher Chapple, Karl-Dietrich Sievert, Scott MacDiarmid, et al.
Emerging Infectious Diseases
|
October 25, 2012
Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011
Katja Hoschler, Catherine Thompson, Nick Andrews, et al.
The Journal of Urology
|
October 19, 2010
Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial
Roger Dmochowski, Christopher Chapple, Victor W Nitti, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
August 6, 2021
Comparison of the Pharmacokinetic Profiles of Trientine Tetrahydrochloride and Trientine Dihydrochloride in Healthy Subjects
Karl Heinz Weiss, Catherine Thompson, Peter Dogterom, et al.
Clinical Infection in Practice
|
December 31, 2019
Adenovirus Type 7 causing severe lower respiratory tract infection in immunocompetent adults: a comparison of two contrasting cases from an intensive care unit in North West England
Tom Wingfield, Luke Dearden, Pete Calvert, et al.
Page
of 8